Nuvasive Profit Margin

The latest profit margin for NUVA is 2.32% as of June 2023. That compares with -3.41% in the prior-year period — up 168.0% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside Nuvasive's historical trend and sector peers before judging valuation or financial health.

Over the past year, NUVA's profit margin moved from -3.41% to 2.32% — a 168.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Nuvasive's valuation or profitability profile.

Against Healthcare companies, NUVA currently prints 2.32% for profit margin, while the sector average sits near 21.34%. That is roughly 89.1% below the sector mean. Large gaps often invite a closer look at Nuvasive's growth, margins, and balance sheet.

Profit Margin shows how effectively Nuvasive converts resources into returns. At 2.32%, NUVA may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -3.41% in the prior-year period — up 168.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting NUVA's profit margin (2.32%), review year-over-year change from -3.41%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.